Selected companies present to venture capital and investment firms representing €10 billion in investment funding as medtech market continues to look for innovation

Lausanne, Switzerland, September 29, 2010 – Bill Muirhead, President of the Medtech Summit, Antoine Papiernik, Vice President of the Selection Committee, and the 21 international members of the Selection Committee of the Medtech Summit announced today which 24 innovative medtech companies will present, at the event to be held this afternoon and tomorrow in Lausanne, Switzerland.

“These companies represent some of the most exciting medtech technologies in Europe and Israel at the moment.” said Bill Muirhead, President of the 2010 Medtech Summit and Chairman and co-founder of biotech company Ayanda Biosystems. “We believe we have selected the most promising technologies which can potentially deliver significant patient benefits in a cost efficient manner to impact global healthcare. Overall, the companies selected represent a great geographic spread and all stages of development from seed to pre-IPO , and have huge potential for further growth.”

The three Swiss companies selected among the 24 finalists are active in diverse fields. CeQur is dedicated to developing and commercializing advanced insulin delivery systems that make it easier for people living with Type 2 diabetes to stay on track with therapy and in control of their disease. Diagnoplex is developing non-invasive cancer screening tests. Sensimed has developed a soft, non-invasive contact lens which encapsulates a telemetric sensor to monitor intraocular pressure continuously up to 24 hours.

“We believe that the market is ready to finance promising medical device ventures, despite the general drought in the financing climate. There are exceptional projects in Europe, as is demonstrated by the line-up of companies presenting at the Summit, and with valuations at a right level, we feel it is a good moment to invest.” states Antoine Papiernik, VP Selection Committee and Managing Partner at Sofinnova.

In addition to the 3 Swiss companies selected to present, the Summit will host an exhibition of medtech companies from Canton of Vaud and the surrounding area chosen to showcase the talent from the region. “This is a fantastic opportunity to really demonstrate the level of expertise in Switzerland in various medtech fields of industry. We hope that the event will help entrepreneurs to find capital and focus investors on the potential of this region.” said Bill Muirhead.


About the European Tech Tour Association

The European Tech Tour Association (ETT) is an independent not-for-profit organization committed to the development of emerging technology companies from Europe. The ETT develops European regional Tech Tours and Vertical Industry Summits that bring together the entire technology ecosystem of local and global players with the aim of facilitating interaction among entrepreneurs, investors and industry players, which eventually leads to facilitating or funding local companies looking to expand internationally. For more information, please see:

More details

Find an actor

ILMAC Lausanne 201803.10.2018

ILMAC Lausanne is the new platform for the chemical & life sciences community. The event will take place on 3 and 4...

Addex Pharma - recoit un financement de 1,2 M£

Addex ADX10061 Receives £1.2 million Funding for Manufacture and Investigator Led Clinical Studies as part of the...

Atracsys SàrlProfessional Services & Consulting
Professional Services & Consulting, Communication / PR / Market research / Events
Professional Services & Consulting, Other

Atracsys a débuté en 2004 en tant que spin-off de l’Ecole Polytechnique Fédérale de Lausanne (EPFL). Acronyme de “Advanced Tracking Systems”, nous développons des systèmes de mesure optique extrêmement précis utilisés quotidiennement par les chirurgiens en salle d’opération. Forts de telles bases techniques, nos ingénieurs se sont inspirés du film “Minority Report” pour créer le premier système d’interaction homme-machine sans contact. En 2007, nous réalisons notre première table multi-touch à reconnaissance d’objets, encore reconnue à ce jour pour sa fiabilité de détection et sa précision.

Aujourd’hui, nous nous focalisons sur la solution complête, du choix du Hardware au développement du Software. Notre laboratoire de R&D teste sans cesse les nouvelles technologies multi-touch du marché et nous optimisons leur utilisation afin de répondre aux objectifs de nos clients. Grâce à nos programmeurs de haut niveau et nos designers d’interface créatifs spécialisés dans les “Natural User Interfaces”, nous sommes devenus une référence dans les domaines de l’amélioration de processus de vente, de communication et de travail à l’aide de la technologie multi-touch.
Depuis 2007, nous avons réalisé plus de 350 projets interactifs pour des multinationales et des PME dans plus de 20 pays à travers le monde.
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn